000 01382 a2200385 4500
005 20250518081616.0
264 0 _c20201118
008 202011s 0 0 eng d
022 _a1742-2094
024 7 _a10.1186/s12974-020-1700-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRibes, Sandra
245 0 0 _aPre-treatment with the viral Toll-like receptor 3 agonist poly(I:C) modulates innate immunity and protects neutropenic mice infected intracerebrally with Escherichia coli.
_h[electronic resource]
260 _bJournal of neuroinflammation
_cJan 2020
300 _a24 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aImmunity, Innate
_xdrug effects
650 0 4 _aImmunocompromised Host
_ximmunology
650 0 4 _aMale
650 0 4 _aMeningitis, Escherichia coli
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNeutropenia
_ximmunology
650 0 4 _aPoly I-C
_ximmunology
650 0 4 _aToll-Like Receptor 3
_xagonists
700 1 _aArcilla, Christa
700 1 _aOtt, Martina
700 1 _aSchütze, Sandra
700 1 _aHanisch, Uwe-Karsten
700 1 _aNessler, Stefan
700 1 _aNau, Roland
773 0 _tJournal of neuroinflammation
_gvol. 17
_gno. 1
_gp. 24
856 4 0 _uhttps://doi.org/10.1186/s12974-020-1700-4
_zAvailable from publisher's website
999 _c30533089
_d30533089